Display options
Share it on

Lung India. 2016 Sep-Oct;33(5):579-80. doi: 10.4103/0970-2113.189000.

Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease.

Lung India : official organ of Indian Chest Society

Silvano Dragonieri, Vitaliano N Quaranta, Pierluigi Carratu, Donato Lacedonia, Giovanna Elisiana Carpagnano, Annamaria Milano, Giuseppina D'Alba, Teresa Ranieri, Maria Pia Foschino Barbaro, Onofrio Resta

Affiliations

  1. Department of Respiratory Diseases, University of Bari, Bari, Italy E-mail: [email protected].
  2. Department of Respiratory Diseases, University of Foggia, Foggia, Italy.

PMID: 27625465 PMCID: PMC5006351 DOI: 10.4103/0970-2113.189000

[No abstract available.]

References

  1. Eur Respir J. 2005 Oct;26(4):630-6 - PubMed
  2. Chest. 2013 May;143(5):1302-11 - PubMed
  3. Int J Chron Obstruct Pulmon Dis. 2006;1(1):91-6 - PubMed
  4. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65 - PubMed
  5. N Engl J Med. 2004 Mar 4;350(10):1005-12 - PubMed
  6. Lancet. 2015 Mar 7;385(9971):857-66 - PubMed

Publication Types